These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Bruce RM; Cohen BH; Diamond EL; Fallat RJ; Knudson RJ; Lebowitz MD; Mittman C; Patterson CD; Tockman MS Am Rev Respir Dis; 1984 Sep; 130(3):386-90. PubMed ID: 6332562 [TBL] [Abstract][Full Text] [Related]
6. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361 [TBL] [Abstract][Full Text] [Related]
7. Interactions of neutrophil elastase, serum trypsin inhibitory activity, and smoking history as risk factors for chronic obstructive pulmonary disease in patients with MM, MZ, and ZZ phenotypes for alpha-antitrypsin. Galdston M; Melnick EL; Goldring RM; Levytska V; Curasi CA; Davis AL Am Rev Respir Dis; 1977 Nov; 116(5):837-46. PubMed ID: 303486 [No Abstract] [Full Text] [Related]
8. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904 [TBL] [Abstract][Full Text] [Related]
9. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type. Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622 [TBL] [Abstract][Full Text] [Related]
10. Interrelationships between serum chemotactic factor inactivator, alpha 1-antitrypsin deficiency, and chronic obstructive lung disease. Lam S; Chan-Yeung M; Abboud R; Kreutzer D Am Rev Respir Dis; 1980 Mar; 121(3):507-12. PubMed ID: 6968167 [TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study. Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777 [TBL] [Abstract][Full Text] [Related]
12. Host factors in chronic obstructive pulmonary disease in an upper Midwest rural community. Design, case selection, and clinical characteristics in a matched-pair study. Miller RD; Hepper NG; Kueppers F; Gordon H; Offord KP Mayo Clin Proc; 1976 Nov; 51(11):709-15. PubMed ID: 1086934 [TBL] [Abstract][Full Text] [Related]
13. The PiMZ phenotype: is it a significant risk factor for the development of chronic obstructive lung disease? Mittman C Am Rev Respir Dis; 1978 Oct; 118(4):649-52. PubMed ID: 309294 [No Abstract] [Full Text] [Related]
14. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Silva GE; Sherrill DL; Guerra S; Barbee RA Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease. Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539 [TBL] [Abstract][Full Text] [Related]
16. Determinants of chronic obstructive pulmonary disease in patients with intermediate levels of alpha-antitrypsin. Klayton R; Fallat R; Cohen AB Am Rev Respir Dis; 1975 Jul; 112(1):71-5. PubMed ID: 238443 [TBL] [Abstract][Full Text] [Related]
17. Physiological studies in a large sibship with antitrypsin deficiency. Duncan PE; Griffin JP Br J Dis Chest; 1975 Apr; 69(2):107-17. PubMed ID: 49190 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Tarján E; Magyar P; Váczi Z; Lantos A; Vaszár L Eur Respir J; 1994 Dec; 7(12):2199-204. PubMed ID: 7713204 [TBL] [Abstract][Full Text] [Related]
19. Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo. Gulsvik A; Fagerhol MK Scand J Respir Dis; 1979 Oct; 60(5):267-74. PubMed ID: 316573 [TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors in chronic obstructive pulmonary disease. Barnett TB; Gottovi D; Johnson AM Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]